Tell your healthcare provider right away if you experience severe stomach or abdominal pain changes in vision, eye pain, burning or swollen eyes, chest pain, confusion, discomfort while urinating or frequent urination, fever, hallucinations or seeing, hearing, or feeling things that are not there, itching, mental depression or other mood or mental changes or suicidality, ringing or buzzing in the ears, shortness of breath, swelling of the face, feet, or lower legs or weight gain
PubMed laboratory research record [PMID: 41631344] PubMed record related to this compound for laboratory literature review
The starting dose period occupies the first 4 to 8 weeks
The anti-inflammatory actions were mediated by inhibiting NF-B and MAPK signaling